- Home :
TumAdoR PROJECT
Developing New Therapeutic Monoclonal Antibodies to neutralize Adenosine immunosuppressive pathway in tumour context
Based on the broad immuno-suppression and strong tumour promotion (proliferation and dissemination) exerted by Adenosine, therapeutic strategies aimed at inhibiting Adenosine are highly promising
- Events
-
- News
-
02 January 2018 Final meeting in Lyon
M54 meeting will be organised by CLB partner on 5 and 6 February 2018.
More >>10 July 2017 M48 meeting in Marseille
Our consortium will meet in Marseille on 6 and 7 September 2017. Innate Pharma kindly organizes this M48 meeting.More >>